UCL Cancer Institute


The UCLH / UCL Cancer Clinical Research Facility (CCRF)


Director: Dr Tim Meyer



The CCRF is a state-of-the-art facility for cancer drug development. Located on the ground floor of the new University College Hospital, the unit provides twenty treatment spaces, clinic rooms, a pharmacy dispensary and a GCLP sample handling laboratory. A broad portfolio of academic and commercially sponsored early phase clinical trials are undertaken, including first in man as well as tumour specific phase I and II trials.

The unit is located within a multidisciplinary hospital with ready access to emergency facilities and intensive care. The UCL Cancer Institute, the new Cancer Centre and the main UCL Campus are all within a few minutes walk providing an outstanding environment for Experimental Cancer Medicine.

UCLH

 

How to Refer a Patient for Phase I Assessment

Email:
phase1cancer@uclh.nhs.uk
Telephone:
+44 (0)20 3447 6036
Post:
Marivic Ricamara,
Sr. Research Nurse,
Clinical Research Facility,
EGA Wing, UCH,
235 Euston Road London
NW1 2BU

View current trials

 






Support and Funding

Funding to develop the unit was provided by the National Institute for Health Research (NIHR), Wellcome Trust, Wolfson Foundation and Cancer Institute Research Trust. Additionally Cancer Research UK and the NIHR provide key infrastructure via the UCL Experimental Cancer Medicine Centre and UCLH / UCL Biomedical Research Unit.



Sarah Cannon Research UK

An important partnership has been established with the Sarah Cannon Research Institute and the newly established Early Phase Trials Unit in Harley Street directed by Dr Tobi Arkenau. This collaboration increases the access for our patients to the latest novel anti-cancer agents though a joint portfolio and establishes a research partnership focused on personalising cancer therapy.

.


 

 



 

Find all information in this brochure: high or low resolution .